$DK

Planned sale of 5,392 Delek US (NYSE: DK) shares disclosed

Amber Russell, a Delek US (DK) shareholder, filed a Form 144 for a potential sale of 5,392 shares valued at $407,096. The shares were acquired through restricted stock vesting. As of September 11, 2026, DK has 61,232,174 shares outstanding on the NYSE. The filing was signed by Joshua Schmitt on behalf of Fidelity Brokerage Services.

Original reporting
Published Sep 11, 2026, 8:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 12, 2026, 4:41 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$DK
Neutral
medium confidence
Mentioned
$DK
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$DKNeutralLow
01

Why it matters

The disclosed sale represents a small fraction of outstanding shares and is unlikely to move the stock significantly.

02

Market read

Primary disclosure of a modest insider sale; limited trading relevance.

03

What to watch

Potential future insider transactions could accumulate if multiple insiders sell.

Relevance 4/10Novelty 4/10Timing: filing date Sep 11 2026

Background

Delek US Holdings (DK) filed a Form 144 indicating a planned insider resale.

Company-level read

Ticker impact

$DKNeutralMedium confidence
Context

Form 144 filing discloses Amber Russell's planned resale of 5,392 DK shares valued at $407,096.

Expected impact

minor downward pressure

Evidence & confidence

The sale size is small relative to market cap; impact likely limited.

Market effects

Minimal effect on the energy sector.

None

Low

Counterpoint

The sale may be a routine liquidity event with no material impact.

Key entities

  • Amber Russell

    Holder of DK shares planning resale.

  • Delek US Holdings, Inc.

    Issuer of the DK common stock.

Related articles

$MPCMed

BTIG warns oil refining stocks face potential correction after record gains

BTIG warns that oil refining stocks may face a correction after the S&P 500 Oil & Gas Refining and Marketing Index gained 124% year-to-date, its best performance in 30 years. The index is 122% above its 200-week moving average, with a weekly RSI of 81. Historically, similar conditions led to declines 7 out of 8 times, with a median 12-week return of -7.2%. BTIG identifies Marathon Petroleum, Valero, Phillips 66, PBF Energy, and Delek Holdings as having poor risk-reward profiles.

$DKMed

Why Delek Holdings Stock Triumphed on Tuesday

Delek US Holdings (DK) will join the S&P SmallCap 600 index on Sept. 21, replacing Brinker International. The stock rose over 5% on the news, likely due to increased visibility and potential index fund inclusion. The change does not alter the company's fundamentals.

$DKMed

Is DK a Buy Now as Cash Flow Improves Despite Refining Cycle Risks?

Delek US Holdings (DK) reported improved cash flow in Q2, with $262.9M from operations. Management expects $220M annual free-cash-flow improvement. DK trades at a forward P/E of 7.1 and P/S of 0.36. Risks include leverage, crack-spread volatility, and regulatory uncertainty. Zacks ranks DK as a Strong Buy with A-rated Value and Growth scores.

$DKMedAI 8/10

Up another 12% Friday, this AI-picked energy stock is now up +90%

Delek US Holdings (DK) surged 11.6% on Friday, reaching near a 52-week high of $71.47, extending its 90% gain since March. The energy company reported Q2 EPS of $5.48, beating estimates by 148%, with EBITDA up 279% quarter-over-quarter. InvestingPro's AI models identified Delek's potential before its rally, citing strong momentum, earnings turnaround, and cost discipline. The company's performance highlights include record refining margins and operational improvements. InvestingPro members recei